Evidence map›Paper›PMID 39117301›Full record

ArticleJournal of movement disorders2024

Evidence-Based Review on Symptomatic Management of Huntington's Disease.

Jung Hwan Shin, Hui-Jun Yang, Jong Hyun Ahn, Sungyang Jo, Seok Jong Chung, Jee-Young Lee, Hyun Sook Kim, Manho Kim, Korean Huntington’s Disease Society

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of movement disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jung Hwan ShinDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Hui-Jun YangDepartment of Neurology, Ulsan University Hospital, Ulsan, Korea.
Jong Hyun AhnDepartment of Neurology, Seoul Samsung Medical Center, Seoul, Korea.
Sungyang JoDepartment of Neurology, Seoul Asan Medical Center, Seoul, Korea.
Seok Jong ChungDepartment of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, Korea.
Jee-Young LeeDepartment of Neurology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Hyun Sook KimDepartment of Neurology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Manho KimDepartment of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Korean Huntington’s Disease Society

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Huntington's disease (HD) is a neurodegenerative disorder characterized by motor, behavioral, and cognitive impairments and significant impacts on patient quality of life. This evidence-based review, conducted by the Korean Huntington Disease Society task force, systematically examines current pharmacological and nonpharmacological interventions for symptomatic management of HD. Following PRISMA guidelines, databases were searched for studies up to August 2022 that focused on 23 symptoms across four domains: motor, neuropsychological, cognition, and others. This review provides a comprehensive and systematic approach to the management of HD, highlighting the need for more high-quality clinical trials to develop robust evidence-based guidelines.

Indexed as

Huntington’s diseaseNon-pharmacologicalPharmacologicalReview

Identifiers

PMID39117301
PMCPMC11540544

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.